TrailBlazer: Self-administered B-12 Injection Non-covered

An Oct. 8 post on TrailBlazer Health Enterprises’ Web site notifies Parts A and B providers that HCPCS Level II code J3420 is no longer covered as a self-administered drug, as indicated on the Self-Administered Drug Exclusions list, effective for service dates on or after Oct. 12.

HCPCS Level II	Descriptor
J3420	Injection, vitamin B-12 cyanocobalamin (Sytobex®, Redisol®, Rubramin PC®, Betalin 12®, Berubigen®, Cobex®, Cobal®, Crystal B12®, Cyano®, Cyanocobalamin®, Hydroxocobalamin®, Hydroxycobal®, Nutri-Twelve®)

 

• Author
• Recent Posts

admin aapc

Latest posts by admin aapc (see all)

• Healthcare in Australia - September 1, 2023
• Get Ready for CMS-HCC V28 - June 30, 2023
• Do You Have a Documentation Emergency? - April 3, 2023

TrailBlazer: Self-administered B-12 Injection Non-covered was last modified: October 19th, 2009 by admin aapc

Related posts:

1. RACs Post New Issues
2. TrailBlazer Updates LCD for Chemo Drugs
3. OIG: Chemo Admin Claims Slip Through System
4. Self-administered B-12 Injection Noncovered

No Responses to “TrailBlazer: Self-administered B-12 Injection Non-covered”

1. Elizabeth D'Aquino says:

   October 22, 2009 at 6:05 am

   As an employee of UVA Health Services Foundation, we were told that injections of B12 given in the OFFICE would no longer be covered. Is that the case? Thanks